Market Cap 597.02M
Revenue (ttm) 0.00
Net Income (ttm) -99.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,389,400
Avg Vol 1,357,376
Day's Range N/A - N/A
Shares Out 95.83M
Stochastic %K 76%
Beta -0.02
Analysts Strong Sell
Price Target $18.83

Company Profile

Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33...

Industry: Biotechnology
Sector: Healthcare
Phone: 702 825 9872
Website: zurabio.com
Address:
1489 W. Warm Springs Road, Suite 110, Henderson, United States
Nudes
Nudes Sep. 4 at 7:55 PM
$ZURA are insiders buying or something
1 · Reply
Nudes
Nudes Sep. 4 at 6:02 PM
$ZURA what’s going on, did I miss anything
2 · Reply
YouVSYou
YouVSYou Sep. 4 at 5:43 PM
$ZURA breakout 6.69 next News coming
0 · Reply
YouVSYou
YouVSYou Sep. 4 at 2:52 PM
$ZURA primed here over 6.09
0 · Reply
TheKogaa
TheKogaa Aug. 26 at 10:24 PM
$ZURA in high confidence trust me bro
1 · Reply
Nudes
Nudes Aug. 24 at 9:38 PM
$ZURA what is happening here
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 6:48 PM
$ZURA Lol. Yep.
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 6:44 PM
$ZURA Curious to see if sellers will continue to take losses at these levels.
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 5:28 PM
$ZURA Lol. All sales are at a loss at these levels.
1 · Reply
partytootie
partytootie Aug. 24 at 5:21 PM
$ZURA 👀
0 · Reply
Latest News on ZURA
Zura Bio management to meet with Piper Sandler

2026-09-04T19:10:10.000Z - 2 days ago

Zura Bio management to meet with Piper Sandler


Zura Bio price target raised to $20 from $15 at Guggenheim

2026-08-17T10:03:14.000Z - 21 days ago

Zura Bio price target raised to $20 from $15 at Guggenheim


Zura Bio price target raised to $22 from $15 at Wedbush

2026-08-17T09:45:11.000Z - 21 days ago

Zura Bio price target raised to $22 from $15 at Wedbush


Zura Bio Slides: Corporate presentation

Aug 11, 2026, 8:00 AM EDT - 27 days ago

Zura Bio Slides: Corporate presentation


Zura Bio reports Q2 EPS (21c), consensus (19c)

2026-08-11T11:36:22.000Z - 27 days ago

Zura Bio reports Q2 EPS (21c), consensus (19c)


Zura Bio sees cash runway through the end of 2028

2026-08-11T11:36:17.000Z - 27 days ago

Zura Bio sees cash runway through the end of 2028


Zura Bio Quarterly report: Q2 2026

Aug 11, 2026, 7:00 AM EDT - 27 days ago

Zura Bio Quarterly report: Q2 2026


Zura Bio Earnings release: Q2 2026

Aug 11, 2026, 7:00 AM EDT - 27 days ago

Zura Bio Earnings release: Q2 2026


Zura Bio initiated with an Outperform at William Blair

2026-07-08T10:55:25.000Z - 2 months ago

Zura Bio initiated with an Outperform at William Blair


Zura Bio Slides: Corporate presentation

Jul 1, 2026, 7:00 AM EDT - 2 months ago

Zura Bio Slides: Corporate presentation


Zura Bio exceeds enrollment target in HS, SSc Phase 2 studies

2026-06-29T11:35:37.000Z - 2 months ago

Zura Bio exceeds enrollment target in HS, SSc Phase 2 studies


Zura Bio sees cash runway through the end of 2028

2026-06-29T11:35:31.000Z - 2 months ago

Zura Bio sees cash runway through the end of 2028


Zura Bio Slides: Corporate presentation

Jun 2, 2026, 7:00 AM EDT - 3 months ago

Zura Bio Slides: Corporate presentation


Zura Bio Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

Zura Bio Proxy statement: Proxy filing


Zura Bio names Muzammil Mustufa chief business officer

2026-05-13T12:19:46.000Z - 3 months ago

Zura Bio names Muzammil Mustufa chief business officer


Zura Bio reports Q1 EPS (22c) vs (19c) last year

2026-05-07T14:42:59.000Z - 4 months ago

Zura Bio reports Q1 EPS (22c) vs (19c) last year


Zura Bio Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Zura Bio Quarterly report: Q1 2026


Zura Bio Earnings release: Q1 2026

May 7, 2026, 7:00 AM EDT - 4 months ago

Zura Bio Earnings release: Q1 2026


Zura Bio Slides: Corporate presentation

May 7, 2026, 7:00 AM EDT - 4 months ago

Zura Bio Slides: Corporate presentation


Zura Bio Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

Zura Bio Proxy statement: Proxy filing


Zura Bio Slides: Corporate presentation

Apr 22, 2026, 7:00 AM EDT - 4 months ago

Zura Bio Slides: Corporate presentation


Zura Bio management to meet virtually with Clear Street

2026-04-16T16:15:53.000Z - 4 months ago

Zura Bio management to meet virtually with Clear Street


Zura Bio management to meet with Piper Sandler

2026-03-23T20:25:55.000Z - 5 months ago

Zura Bio management to meet with Piper Sandler


Zura Bio price target lowered to $15 from $16 at Oppenheimer

2026-03-20T11:41:41.000Z - 5 months ago

Zura Bio price target lowered to $15 from $16 at Oppenheimer


Zura Bio reports FY25 EPS ($1.06) vs (60c) last year

2026-03-19T20:16:13.000Z - 5 months ago

Zura Bio reports FY25 EPS ($1.06) vs (60c) last year


Zura Bio Annual report: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 5 months ago

Zura Bio Annual report: Q4 2025


Zura Bio Earnings release: Q4 2025

Mar 19, 2026, 4:00 PM EDT - 5 months ago

Zura Bio Earnings release: Q4 2025


Zura Bio Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 6 months ago

Zura Bio Transcript: Leerink Global Healthcare Conference 2026


Zura Bio Slides: Corporate presentation

Mar 10, 2026, 7:00 AM EDT - 6 months ago

Zura Bio Slides: Corporate presentation


Zura Bio to Participate in Upcoming Investor Conferences

Mar 2, 2026, 6:30 AM EST - 6 months ago

Zura Bio to Participate in Upcoming Investor Conferences


Zura Bio 18.2M share Spot Secondary priced at $6.25

2026-02-25T12:39:16.000Z - 6 months ago

Zura Bio 18.2M share Spot Secondary priced at $6.25


Zura Bio announces common stock offering, amount not stated

2026-02-24T22:02:41.000Z - 6 months ago

Zura Bio announces common stock offering, amount not stated


Zura Bio spot secondary offering; price range $6.00-$6.25

2026-02-24T22:02:21.000Z - 6 months ago

Zura Bio spot secondary offering; price range $6.00-$6.25


Zura Bio Slides: Corporate presentation

Feb 11, 2026, 7:00 AM EST - 6 months ago

Zura Bio Slides: Corporate presentation


Zura Bio Reports Business Updates and Outlook for 2026

Jan 12, 2026, 6:30 AM EST - 7 months ago

Zura Bio Reports Business Updates and Outlook for 2026


Zura Bio Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 9 months ago

Zura Bio Earnings release: Q3 2025


Zura Bio Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 9 months ago

Zura Bio Quarterly report: Q3 2025


Zura Bio Slides: Corporate Presentation

Sep 2, 2025, 6:00 PM EDT - 1 year ago

Zura Bio Slides: Corporate Presentation


Zura Bio Quarterly report: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Zura Bio Quarterly report: Q2 2025


Zura Bio Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Zura Bio Earnings release: Q2 2025


Zura Bio Announces Chief Financial Officer Transition

Jul 1, 2025, 6:30 AM EDT - 1 year ago

Zura Bio Announces Chief Financial Officer Transition


Zura Bio Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Zura Bio Quarterly report: Q1 2025


Zura Bio Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Zura Bio Earnings release: Q1 2025


Zura Bio Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Zura Bio Proxy statement: Proxy Filing


Zura Bio Annual report: Q4 2024

Mar 25, 2025, 7:00 AM EDT - 1 year ago

Zura Bio Annual report: Q4 2024


Zura Bio Earnings release: Q4 2024

Mar 25, 2025, 7:00 AM EDT - 1 year ago

Zura Bio Earnings release: Q4 2024


Zura Bio Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Zura Bio Quarterly report: Q3 2024


Zura Bio Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Zura Bio Earnings release: Q3 2024


Zura Bio Registration statement: Registration Filing

Sep 16, 2024, 8:00 AM EDT - 1 year ago

Zura Bio Registration statement: Registration Filing


Zura Bio Proxy statement: Proxy Filing

Sep 13, 2024, 8:00 AM EDT - 1 year ago

Zura Bio Proxy statement: Proxy Filing


Zura Bio Proxy statement: Proxy Filing

Sep 13, 2024, 8:00 AM EDT - 1 year ago

Zura Bio Proxy statement: Proxy Filing


Zura Bio Registration statement: Registration Filing

Sep 11, 2024, 8:00 AM EDT - 1 year ago

Zura Bio Registration statement: Registration Filing


Zura Bio Registration statement: Registration Filing

Sep 3, 2024, 8:00 AM EDT - 2 years ago

Zura Bio Registration statement: Registration Filing


Zura Bio Quarterly report: Q2 2024

Aug 13, 2024, 9:30 AM EDT - 2 years ago

Zura Bio Quarterly report: Q2 2024


Zura Bio Earnings release: Q2 2024

Aug 13, 2024, 9:30 AM EDT - 2 years ago

Zura Bio Earnings release: Q2 2024


Zura Bio Announces Participation in June Investor Conferences

May 29, 2024, 6:00 AM EDT - 2 years ago

Zura Bio Announces Participation in June Investor Conferences


Zura Bio Registration statement: Registration Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Zura Bio Registration statement: Registration Filing


Zura Bio Quarterly report: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Zura Bio Quarterly report: Q1 2024


Zura Bio Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

Zura Bio Earnings release: Q1 2024


Zura Bio Announces Robert Lisicki as CEO and Director

Apr 8, 2024, 6:00 AM EDT - 2 years ago

Zura Bio Announces Robert Lisicki as CEO and Director


Zura Bio Annual report: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Zura Bio Annual report: Q4 2023


Zura Bio Earnings release: Q4 2023

Mar 28, 2024, 5:00 PM EDT - 2 years ago

Zura Bio Earnings release: Q4 2023


Zura Bio Announces Participation at March Conferences

Mar 4, 2024, 6:00 AM EST - 2 years ago

Zura Bio Announces Participation at March Conferences


Nudes
Nudes Sep. 4 at 7:55 PM
$ZURA are insiders buying or something
1 · Reply
Nudes
Nudes Sep. 4 at 6:02 PM
$ZURA what’s going on, did I miss anything
2 · Reply
YouVSYou
YouVSYou Sep. 4 at 5:43 PM
$ZURA breakout 6.69 next News coming
0 · Reply
YouVSYou
YouVSYou Sep. 4 at 2:52 PM
$ZURA primed here over 6.09
0 · Reply
TheKogaa
TheKogaa Aug. 26 at 10:24 PM
$ZURA in high confidence trust me bro
1 · Reply
Nudes
Nudes Aug. 24 at 9:38 PM
$ZURA what is happening here
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 6:48 PM
$ZURA Lol. Yep.
1 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 6:44 PM
$ZURA Curious to see if sellers will continue to take losses at these levels.
0 · Reply
Trigga_tha_Gambler
Trigga_tha_Gambler Aug. 24 at 5:28 PM
$ZURA Lol. All sales are at a loss at these levels.
1 · Reply
partytootie
partytootie Aug. 24 at 5:21 PM
$ZURA 👀
0 · Reply
YouVSYou
YouVSYou Aug. 24 at 3:14 PM
$ZURA brb 6.29/6.56 6.83/7.10 above
0 · Reply
THE_MADMAN
THE_MADMAN Aug. 24 at 3:06 PM
$ZURA what's going on
0 · Reply
kp8claw
kp8claw Aug. 24 at 3:03 PM
$ZURA | $6.86 | Vol: 1.81M | RE·RVOL=1.91·F=51M | MUP_1 | Long
1 · Reply
TheeVoid
TheeVoid Aug. 21 at 8:56 PM
$ZURA $205M cash as of June 30, 2026, with runway expected into 2028..
0 · Reply
luminouslumens
luminouslumens Aug. 14 at 1:19 AM
2 · Reply
STACKD0E
STACKD0E Aug. 11 at 12:06 PM
0 · Reply
BanditQ
BanditQ Jul. 12 at 9:45 PM
$ZURA will get back into this soon
0 · Reply
BioTuesdays
BioTuesdays Jul. 8 at 6:21 PM
William Blair launched coverage of Zura Bio $ZURA with an “outperform” rating and sum-of-the-parts NPV estimate of $13.90. The stock closed at $5.08 on July 7. https://biotuesdays.com/2026/07/08/wb-starts-zura-bio-at-op-sum-of-the-parts-npv-estimate-13-90/
0 · Reply
notreload_ai
notreload_ai Jul. 8 at 1:34 PM
William Blair initiated coverage on $ZURA with an Outperform rating, citing strong upside potential for lead candidate tibulizumab in hidradenitis suppurativa and systemic sclerosis. https://notreload.xyz/xy/william-blair-initiates-outperform-coverage-on-zura-citing-strong-potential-for-tibulizumab/
0 · Reply
gstock568
gstock568 Jul. 6 at 11:50 PM
$LIMN It will be interesting to see what PR comes out that is essentially necessary to explain this SPAC/Business combination... TBD A car seat company: Ewon Comfortech Co., Ltd. https://www.sec.gov/Archives/edgar/data/1973072/000110465926080804/xslF345X06/tm2619639-2_3seq1.xml A blood company: Valetudo Med Tech https://valetudomedtech.com/dr-cazzoli/ https://www.sec.gov/Archives/edgar/data/1971387/000110465926080806/xslF345X06/tm2619639-1_4seq1.xml A bio company : $ZURA ZURA BIO LIMITED https://www.sec.gov/Archives/edgar/data/1855644/000110465926079538/tm2619483d1_ex99-1.htm Kim Davis, JD... Prior to joining Zura, Ms. Davis served as Vice President, Deputy General Counsel, and Chief Compliance Officer at Arena Pharmaceuticals, Inc. from 2020 until the company’s acquisition by Pfizer in September 2022. From 2014 to 2020, she was Vice President and Chief Compliance Officer at Kaleo, Inc. Earlier in her career, she served as Vice President and Health Care Law & Compliance Officer at Impax Laboratories, Inc. (now Amneal Pharmaceuticals LLC) from 2011 to 2014. Ms. Davis previously held senior legal leadership roles at Amgen, Inc., including serving as Executive Director from 2008 to 2011 and Associate General Counsel... TBD???
1 · Reply
BanditQ
BanditQ Jun. 30 at 7:40 PM
$TENX can't stop winning $EQ $QCLS $ZURA
2 · Reply
SannieVerraderlijk
SannieVerraderlijk Jun. 30 at 4:37 PM
$ABVX $CCCC $ZURA Top-3 largest holdings on fire
0 · Reply